Innoviva, Inc. Common Stock earnings per share and revenue
On Nov 05, 2025, INVA reported earnings of 1.08 USD per share (EPS) for Q3 25, beating the estimate of 0.49 USD, resulting in a 119.42% surprise. Revenue reached 107.80 million, compared to an expected 93.13 million, with a 15.75% difference. The market reacted with a +12.89% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of 0.61 USD, with revenue projected to reach 103.56 million USD, implying an decrease of -43.52% EPS, and decrease of -3.93% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Johnson & Johnson
Report Date
Jan 21, 2026 For Q4 25
Estimate
$2.46
Actual
$2.46
Surprise
-0.13%
FAQ
What were Innoviva, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Innoviva, Inc. Common Stock reported EPS of $1.08, beating estimates by 119.42%, and revenue of $107.80M, 15.75% above expectations.
How did the market react to Innoviva, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 12.89%, changed from $18.23 before the earnings release to $20.58 the day after.
When is Innoviva, Inc. Common Stock expected to report next?
The next earning report is scheduled for Feb 24, 2026.
What are the forecasts for Innoviva, Inc. Common Stock's next earnings report?
Based on 6
analysts, Innoviva, Inc. Common Stock is expected to report EPS of $0.61 and revenue of $103.56M for Q4 2025.